Hutch News

Hutch News

Stories tagged 'Seth Pollack'

3 new projects map out immune responses to cancers

Scientists aim to gather knowledge that improves future immunotherapies

July 30, 2018 | By Susan Keown / Fred Hutch News Service

The immune system has the potential to eradicate cancer. But cancers are expert escape artists, with numerous tools for shutting down or hiding from immune attack. Three research teams at Fred Hutch have launched new projects aimed at revealing some of these secrets and laying the groundwork for developing better immune-harnessing cancer therapies, or immunotherapies.

View story >


Fred Hutch at ASCO

Immunotherapy advances, insights into health economics and leadership awards dominate oncology gathering

June 5, 2018 | By Fred Hutch staff

Immunotherapy advances, insights into health economics and leadership awards dominate oncology gathering

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Oct. 26, 2017

Fred Hutch leader Dr. Gary Gilliland addressed lawmakers at a hearing to discuss NIH funding for biomedical research, particularly the role of a type of funding called facilities and administrative costs.

View story >


Teacher, mom — and living proof of principle

Three years ago she was out of options to treat her advanced cancer. Then, she enrolled in an immunotherapy clinical trial.

Sept. 8, 2017 | By Susan Keown / Fred Hutch News Service

When Tiffany's advanced cancer kept coming back, she decided to become the first person in the world to receive a still-experimental new immunotherapy.

View story >


Using a virus to teach the immune system to kill cancer

‘Exciting’ results from early trial spurs further development of novel vaccine for sarcoma

June 2, 2017 | By Susan Keown / Fred Hutch News Service

This cancer vaccine uses a virus to teach sarcoma patients’ immune systems to kill tumor cells. It was tested in an early-stage clinical trial.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

May 4, 2017

First extensive immune profiling of sarcomas shows some types may be susceptible to immunotherapy; Fred Hutch hosts first-of-its-kind regional conference for science communicators; and Pathway that regulates organ size may also underlie tumors’ resistance to certain chemotherapy drugs.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.